Is this a repeat of Google’s bait and switch? You pay to have your DNA tested, then this evil company sneakily sells the mining rights of the data and makes royalties on new pharmaceuticals.
STORY AT-A-GLANCE
GlaxoSmithKline (GSK) will pay 23andMe $20 million to extend its five-year contract to mine the company’s consumer DNA data for another year
The drugmaker is searching for hints about genes that might be at the root of disease. 23andMe will get royalties on any drugs developed
Posted in